Evidence map›Paper›PMID 32795243›Full record

ReviewGut microbes2020

Research in a time of enteroids and organoids: how the human gut model has transformed the study of enteric bacterial pathogens.

Sridevi Ranganathan, Emily M Smith, Jennifer D Foulke-Abel, Eileen M Barry

Abstract readReview
In one paragraph

Review in Gut microbes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Characterization of the role of putativeJournal of bacteriology · 2026
    Article
  2. Review
  3. EnteroaggregativeEcoSal Plus · 2025
    Review
  4. Review
  5. Article
  6. Unravelling three-way interactions betweenJournal of medical microbiology · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Shigella-Controlled Human Infection Models: Current and Future Perspectives.Current topics in microbiology and immunology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sridevi RanganathanCenter for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, MD, USA.ORCID 0000-0002-9684-2004
Emily M SmithCenter for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, MD, USA.ORCID 0000-0002-3312-833X
Jennifer D Foulke-AbelDepartment of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine , Baltimore, MD, USA.ORCID 0000-0003-3882-5625
Eileen M BarryCenter for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, MD, USA.ORCID 0000-0002-5326-0047

Funding

Shigella Live Vector-Based Multivalent VaccineU19AI109776 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2014 to 2018
$25.4M
Project 3 - Human colonoids as a model for the pathobiology of EHECP01AI125181 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI ZACHOS, NICHOLAS CONSTANTINE · 2016 to 2025
$18.6M
Probiotic yeast secreting single-domain antibodies to prevent Clostridium difficile and Campylobacter jejuni diseaseU19AI142725 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2019 to 2023
$12.5M
Translational Research Enhancement CoreP30DK089502 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI ZACHOS, NICHOLAS CONSTANTINE · 2011 to 2020
$12.0M
A Human Enteroid Model of Cholera Toxin PathophysiologyK01DK113043 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI FOULKE-ABEL, JENNIFER · 2018 to 2022
$791k
Advanced components for an existing spinning disk confocal in an established core imaging facilityS10OD026698 · OD · UNIVERSITY OF MARYLAND BALTIMORE · PI BLANPIED, THOMAS A · 2019 to 2019
$274k
NIAID NIH HHS P01 AI125181NIAID NIH HHS U19 AI109776NIAID NIH HHS U19 AI142725NIDDK NIH HHS K01 DK113043NIDDK NIH HHS P30 DK089502NIH HHS S10 OD026698
6 · The paper itself

Abstract

Enteric bacterial pathogens cause significant morbidity and mortality globally. Studies in tissue culture and animal models shaped our initial understanding of these host-pathogen interactions. However, intrinsic shortcomings in these models limit their application, especially in translational applications like drug screening and vaccine development. Human intestinal enteroid and organoid models overcome some limitations of existing models and advance the study of enteric pathogens. In this review, we detail the use of human enteroids and organoids to investigate the pathogenesis of invasive bacteria

Indexed as

Models, BiologicalBacteriaGastrointestinal DiseasesGastrointestinal TractHost-Pathogen InteractionsHumansOrganoidsbacterial pathogensenteric bacteriaHuman intestinal enteroidsorganoids

Identifiers

PMID32795243
PMCPMC7524385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.